These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 1100305)
1. Pharmacokinetics of indomethacin. Alván G; Orme M; Bertilsson L; Ekstrand R; Palmér L Clin Pharmacol Ther; 1975 Sep; 18(3):364-73. PubMed ID: 1100305 [TBL] [Abstract][Full Text] [Related]
2. Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories. Jensen KM; Grenabo L Acta Pharmacol Toxicol (Copenh); 1985 Nov; 57(5):322-7. PubMed ID: 4090993 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories. Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614 [TBL] [Abstract][Full Text] [Related]
4. Absorption and bioavailability of calcium and magnesium salts of indomethacin from rectal suppositories. Ogiso T; Iwaki M; Tamaki E J Pharmacobiodyn; 1984 Jun; 7(6):392-9. PubMed ID: 6548261 [TBL] [Abstract][Full Text] [Related]
5. Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate. Kaldestad E; Hansen T; Brath HK Eur J Clin Pharmacol; 1975 Dec; 9(2-3):199-207. PubMed ID: 1233265 [TBL] [Abstract][Full Text] [Related]
6. A comparison of oral and intravenous indomethacin dispositions in the premature infant with patent ductus arteriosus. Evans M; Bhat R; Vidyasagar D; Patel M; Hastreiter A Pediatr Pharmacol (New York); 1981; 1(3):251-8. PubMed ID: 7346745 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers. Kölle EU; Vollmer KO Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273 [TBL] [Abstract][Full Text] [Related]
8. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers. He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976 [TBL] [Abstract][Full Text] [Related]
9. [Experimental study of an ampicillin suppository (KS-R1) in adults and children]. Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K Jpn J Antibiot; 1983 Jul; 36(7):1713-68. PubMed ID: 6655809 [TBL] [Abstract][Full Text] [Related]
10. Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man. Kwan KC; Breault GO; Davis RL; Lei BW; Czerwinski AW; Besselaar GH; Duggan DE J Pharmacokinet Biopharm; 1978 Dec; 6(6):451-76. PubMed ID: 731412 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetic comparison of two indometacin containing suppositories with different vehicula. Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A Arzneimittelforschung; 1984; 34(4):523-5. PubMed ID: 6547611 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration. Breimer DD; de Boer AG Arzneimittelforschung; 1976; 26(3):448-54. PubMed ID: 989344 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of oral and intravenous indomethacin in preterm infants. Bhat R; Vidyasagar D; Fisher E; Hastreiter A; Ramirez JL; Burns L; Evans M Dev Pharmacol Ther; 1980; 1(2-3):101-10. PubMed ID: 6927543 [TBL] [Abstract][Full Text] [Related]
14. Single-dose kinetics and bioavailability of ketobemidone. Anderson P; Arnér S; Bondesson U; Boréus LO; Hartvig P Acta Anaesthesiol Scand Suppl; 1982; 74():59-62. PubMed ID: 6124079 [TBL] [Abstract][Full Text] [Related]
15. Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers. Eandi M; Viano I; Ricci Gamalero S Arzneimittelforschung; 1984; 34(8):903-7. PubMed ID: 6548636 [TBL] [Abstract][Full Text] [Related]
16. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers. Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a single intravenous and oral dose of pafenolol--a beta 1-adrenoceptor antagonist with atypical absorption and disposition properties--in man. Regårdh CG; Lundborg P; Gabrielsson M; Heggelund A; Kylberg-Hanssen K Pharm Res; 1990 Dec; 7(12):1222-7. PubMed ID: 1982773 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration. Patel IH; Levy RH; Bauer TG Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects. Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]